ArticleBritish journal of cancer2026

A plasma derived hypoxia signature predicts benefit from hypoxia-modifying radiotherapy and reveals dynamic humoral immune modulation in bladder cancer.

C Guerrero Quiles et al.PubMed ↗Publisher ↗

No numbers read from the abstract.